The estimated Net Worth of E Lee Bendekgey is at least 4.41 百万$ dollars as of 13 July 2020. Mr Bendekgey owns over 27,500 units of Invitae Corp stock worth over 4,916$ and over the last 9 years he sold NVTA stock worth over 4,017,125$. In addition, he makes 383,644$ as Chief Policy Officer at Invitae Corp.
Mr has made over 11 trades of the Invitae Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 27,500 units of NVTA stock worth 77,550$ on 13 July 2020.
The largest trade he's ever made was selling 119,789 units of Invitae Corp stock on 26 February 2020 worth over 2,486,820$. On average, Mr trades about 12,904 units every 69 days since 2015. As of 13 July 2020 he still owns at least 245,811 units of Invitae Corp stock.
You can see the complete history of Mr Bendekgey stock trades at the bottom of the page.
Lee Bendekgey is the Chief Policy Officer at Invitae Corp.
As the Chief Policy Officer of Invitae Corp, the total compensation of Mr Bendekgey at Invitae Corp is 383,644$. There are 6 executives at Invitae Corp getting paid more, with Sean George having the highest compensation of 5,319,510$.
Mr Bendekgey is 63, he's been the Chief Policy Officer of Invitae Corp since . There are 2 older and 16 younger executives at Invitae Corp. The oldest executive at Invitae Corp is Dr. Robert L. Nussbaum, 71, who is the Chief Medical Officer.
E's mailing address filed with the SEC is C/O INVITAE CORPORATION, 1400 16TH STREET, SAN FRANCISCO, CA, 94103.
Over the last 10 years, insiders at Invitae Corp have traded over 68,349,838$ worth of Invitae Corp stock and bought 2,982,686 units worth 18,086,236$ . The most active insiders traders include Bros. Advisors Lp Baker Bro...、Bros. Advisors Lpbaker Feli...、James E Deerfield Mgmt L.P..... On average, Invitae Corp executives and independent directors trade stock every 14 days with the average trade being worth of 540$. The most recent stock trade was executed by Robert L Nussbaum on 13 June 2023, trading 7,086 units of NVTA stock currently worth 9,779$.
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
Invitae Corp executives and other stock owners filed with the SEC include: